Cargando…
Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2
BACKGROUND: Hermansky-Pudlak syndrome 2 (HPS2; OMIM #608233) is a rare, autosomal recessive disorder caused by loss-of-function genetic variations affecting AP3B1, which encodes the β3A subunit of the adaptor-related protein complex 3 (AP3). Phenotypic characteristics include reduced pigmentation, a...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663694/ https://www.ncbi.nlm.nih.gov/pubmed/23557002 http://dx.doi.org/10.1186/1471-2350-14-42 |
_version_ | 1782271021161644032 |
---|---|
author | Jones, Matthew L Murden, Sherina L Brooks, Claire Maloney, Viv Manning, Richard A Gilmour, Kimberly C Bharadwaj, Vandana de la Fuente, Josu Chakravorty, Subarna Mumford, Andrew D |
author_facet | Jones, Matthew L Murden, Sherina L Brooks, Claire Maloney, Viv Manning, Richard A Gilmour, Kimberly C Bharadwaj, Vandana de la Fuente, Josu Chakravorty, Subarna Mumford, Andrew D |
author_sort | Jones, Matthew L |
collection | PubMed |
description | BACKGROUND: Hermansky-Pudlak syndrome 2 (HPS2; OMIM #608233) is a rare, autosomal recessive disorder caused by loss-of-function genetic variations affecting AP3B1, which encodes the β3A subunit of the adaptor-related protein complex 3 (AP3). Phenotypic characteristics include reduced pigmentation, absent platelet dense granule secretion, neutropenia and reduced cytotoxic T lymphocyte (CTL) and natural killer (NK) cell function. To date HPS2 has been associated with non-synonymous, stop-gain or deletion-insertion nucleotide variations within the coding region of AP3B1. CASE PRESENTATION: We describe a consanguineous female infant with reduced pigmentation, neutropenia and recurrent infections. Platelets displayed reduced aggregation and absent ATP secretion in response to collagen and ADP, indicating a platelet dense granule defect. There was increased basal surface expression of CD107a (lysosome-associated membrane protein 1(LAMP-1)) on NK cells and CTLs from the study subject and a smaller increase in the percentage of CD107a positive cells after stimulation compared to most healthy controls. Immunoblotting of protein extracts from EBV-transformed lymphoblasts from the index case showed absent expression of full-length AP-3 β3A subunit protein, confirming a phenotypic diagnosis of HPS2. The index case displayed a homozygous pericentric inv(5)(p15.1q14.1), which was also detected as a heterozygous defect in both parents of the index case. No loss of genetic material was demonstrated by microarray comparative genome hybridisation at 60kb resolution. Fluorescence in-situ hybridisation using the 189.6kb probe RP11-422I12, which maps to 5q14.1, demonstrated dual hybridisation to both 5q14.1 and 5p15.1 regions of the inverted Chr5. The RP11-422I12 probe maps from intron 1 to intron 16 of AP3B1, thus localising the 5q inversion breakpoint to within AP3B1. The probe RP11-211K15, which corresponds to an intergenic region on 5p also showed dual hybridisation, enabling localisation of the 5p inversion breakpoint. CONCLUSION: This case report extends the phenotypic description of the very rare disorder HPS2. Our demonstration of a homozygous Chr5 inversion predicted to disrupt AP3B1 gene provides a novel pathogenic mechanism for this disorder. |
format | Online Article Text |
id | pubmed-3663694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36636942013-05-25 Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2 Jones, Matthew L Murden, Sherina L Brooks, Claire Maloney, Viv Manning, Richard A Gilmour, Kimberly C Bharadwaj, Vandana de la Fuente, Josu Chakravorty, Subarna Mumford, Andrew D BMC Med Genet Case Report BACKGROUND: Hermansky-Pudlak syndrome 2 (HPS2; OMIM #608233) is a rare, autosomal recessive disorder caused by loss-of-function genetic variations affecting AP3B1, which encodes the β3A subunit of the adaptor-related protein complex 3 (AP3). Phenotypic characteristics include reduced pigmentation, absent platelet dense granule secretion, neutropenia and reduced cytotoxic T lymphocyte (CTL) and natural killer (NK) cell function. To date HPS2 has been associated with non-synonymous, stop-gain or deletion-insertion nucleotide variations within the coding region of AP3B1. CASE PRESENTATION: We describe a consanguineous female infant with reduced pigmentation, neutropenia and recurrent infections. Platelets displayed reduced aggregation and absent ATP secretion in response to collagen and ADP, indicating a platelet dense granule defect. There was increased basal surface expression of CD107a (lysosome-associated membrane protein 1(LAMP-1)) on NK cells and CTLs from the study subject and a smaller increase in the percentage of CD107a positive cells after stimulation compared to most healthy controls. Immunoblotting of protein extracts from EBV-transformed lymphoblasts from the index case showed absent expression of full-length AP-3 β3A subunit protein, confirming a phenotypic diagnosis of HPS2. The index case displayed a homozygous pericentric inv(5)(p15.1q14.1), which was also detected as a heterozygous defect in both parents of the index case. No loss of genetic material was demonstrated by microarray comparative genome hybridisation at 60kb resolution. Fluorescence in-situ hybridisation using the 189.6kb probe RP11-422I12, which maps to 5q14.1, demonstrated dual hybridisation to both 5q14.1 and 5p15.1 regions of the inverted Chr5. The RP11-422I12 probe maps from intron 1 to intron 16 of AP3B1, thus localising the 5q inversion breakpoint to within AP3B1. The probe RP11-211K15, which corresponds to an intergenic region on 5p also showed dual hybridisation, enabling localisation of the 5p inversion breakpoint. CONCLUSION: This case report extends the phenotypic description of the very rare disorder HPS2. Our demonstration of a homozygous Chr5 inversion predicted to disrupt AP3B1 gene provides a novel pathogenic mechanism for this disorder. BioMed Central 2013-04-04 /pmc/articles/PMC3663694/ /pubmed/23557002 http://dx.doi.org/10.1186/1471-2350-14-42 Text en Copyright © 2013 Jones et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Jones, Matthew L Murden, Sherina L Brooks, Claire Maloney, Viv Manning, Richard A Gilmour, Kimberly C Bharadwaj, Vandana de la Fuente, Josu Chakravorty, Subarna Mumford, Andrew D Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2 |
title | Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2 |
title_full | Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2 |
title_fullStr | Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2 |
title_full_unstemmed | Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2 |
title_short | Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2 |
title_sort | disruption of ap3b1 by a chromosome 5 inversion: a new disease mechanism in hermansky-pudlak syndrome type 2 |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663694/ https://www.ncbi.nlm.nih.gov/pubmed/23557002 http://dx.doi.org/10.1186/1471-2350-14-42 |
work_keys_str_mv | AT jonesmatthewl disruptionofap3b1byachromosome5inversionanewdiseasemechanisminhermanskypudlaksyndrometype2 AT murdensherinal disruptionofap3b1byachromosome5inversionanewdiseasemechanisminhermanskypudlaksyndrometype2 AT brooksclaire disruptionofap3b1byachromosome5inversionanewdiseasemechanisminhermanskypudlaksyndrometype2 AT maloneyviv disruptionofap3b1byachromosome5inversionanewdiseasemechanisminhermanskypudlaksyndrometype2 AT manningricharda disruptionofap3b1byachromosome5inversionanewdiseasemechanisminhermanskypudlaksyndrometype2 AT gilmourkimberlyc disruptionofap3b1byachromosome5inversionanewdiseasemechanisminhermanskypudlaksyndrometype2 AT bharadwajvandana disruptionofap3b1byachromosome5inversionanewdiseasemechanisminhermanskypudlaksyndrometype2 AT delafuentejosu disruptionofap3b1byachromosome5inversionanewdiseasemechanisminhermanskypudlaksyndrometype2 AT chakravortysubarna disruptionofap3b1byachromosome5inversionanewdiseasemechanisminhermanskypudlaksyndrometype2 AT mumfordandrewd disruptionofap3b1byachromosome5inversionanewdiseasemechanisminhermanskypudlaksyndrometype2 |